1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (2745)
  2. Meeting Abstract (2507)
  3. Review (113)
  4. Book Section (82)
  5. Editorial (52)
  6. Correspondence (33)
  7. Conference Paper (29)
  8. Guidelines (24)
  9. Research Letter (15)
  10. Book Whole (4)
  11. Miscellaneous (4)
Groups
  1. Genitourinary Oncology Service (5608)
  2. Solid Tumor Oncology Division (5608)
  3. Department of Medicine (5598)
  4. GSK Faculty (1640)
  5. Human Oncology and Pathogenesis Program (1139)
  6. Department of Pathology and Laboratory Medicine (1034)

More Groups

People
  1. Robert Motzer (1243)
  2. Howard Scher (1130)
  3. David Solit (779)
  4. Dean Bajorin (657)
  5. Michael Morris (577)
  6. Jonathan Rosenberg (510)

More People

Years
  1. 2025 (118)
  2. 2024 (293)
  3. 2023 (283)
  4. 2022 (314)
  5. 2021 (341)
  6. 2020 (352)

More Years

Publications
  1. Journal of Clinical Oncology (1697)
  2. Annals of Oncology (303)
  3. Clinical Cancer Research (282)
  4. Cancer Research (245)
  5. Cancer (125)
  6. European Urology (118)

More Publications

Publishers
  1. American Society of Clinical Oncology (1757)
  2. American Association for Cancer Research (688)
  3. Oxford University Press (408)
  4. Elsevier Science, Inc. (389)
  5. Elsevier Inc. (384)
  6. Nature Publishing Group (294)

More Publishers

Results (5608)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A randomized, open label, multicenter, phase 3, 2-arm study of androgen deprivation with leuprolide (L), +/- docetaxel (D) for clinically asymptomatic prostate cancer (PC) subjects with a rising PSA following definitive local therapy: Safety results
    Meeting Abstract

    Morris, M. J.; Gleave, M. E.; Armstrong, A. J.; Carducci, M. A.; Saad, F.; Lacuna, K. P.; Scher, H. I.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Female germ cell tumors (GCT): The Memorial Sloan Kettering Cancer Center (MSKCC) experience
    Meeting Abstract

    Meisel, J. L.; Woo, K.; Sudarsan, N.; Eng, J.; Patil, S.; Jacobsen, E. P.; Murali, R.; Motzer, R. J.; Bosl, G. J.; Aghajanian, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A phase I/II study to assess the safety and efficacy of pazopanib and MK-3475 in subjects with advanced renal cell carcinoma
    Meeting Abstract

    McDermott, D. F.; Infante, J. R.; Voss, M. H.; Motzer, R. J.; Haanen, J. B. A. G.; Chowdhury, S.; Perini, R. F.; Iannone, R.; Hodge, R.; Figueroa, D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of oral BKM120 and oral olaparib for high-grade serous ovarian cancer (HGSC) or triple-negative breast cancer (TNBC)
    Meeting Abstract

    Matulonis, U.; Wulf, G. M.; Birrer, M. J.; Westin, S. N.; Quy, P.; Bell-Mcguinn, K. M.; Lasonde, B.; Whalen, C.; Aghajanian, C.; Solit, D. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Safety results of the enzalutamide expanded access program in the United States and Canada for patients with metastatic castration-resistant prostate cancer (mCRPC) previously treated with docetaxel
    Meeting Abstract

    Joshua, A. M.; Shore, N. D.; Saad, F.; Chi, K. N.; Olsson, C. A.; Emmenegger, U.; Scholz, M. C.; Berry, W. R.; Mukherjee, S.; Winquist, E.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Genome-wide association study (GWAS) of efficacy and safety endpoints in pazopanib- or sunitinib-treated patients with renal cell carcinoma (RCC)
    Meeting Abstract

    Johnson, T.; Xu, C. F.; Choueiri, T. K.; Figlin, R. A.; Sternberg, C. N.; King, K. S.; Xue, Z. Y.; Stinnett, S.; Deen, K. C.; Carpenter, C.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The effect of SETD2 mutation (mts) on histone 3 lysine 36 trimethylation (H3K36me3) and correlation with clinical outcome in patients (pts) with metastatic clear cell renal cell carcinoma (ccRCC) enrolled in COMPARZ
    Meeting Abstract

    Ho, T. H.; Choueiri, T. K.; D'Amelio, A.; Hsieh, J.; De Souza, P. L.; Deen, K. C.; Langmuir, P. B.; Liu, Y.; Motzer, R. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A genome-wide association study (GWAS) of docetaxel-induced neutropenia in CALGB 90401/60404 (Alliance)
    Meeting Abstract

    Hertz, D. L.; Jiang, C.; Owzar, K.; Halabi, S.; Kelly, W. K.; Mulkey, F.; Patel, J. N.; Carducci, M. A.; Kelley, M. J.; Stadler, W. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase I study of nivolumab in combination with ipilimumab in metastatic renal cell carcinoma (mRCC)
    Meeting Abstract

    Hammers, H. J.; Plimack, E. R.; Infante, J. R.; Ernstoff, M. S.; Rini, B. I.; McDermott, D. F.; Razak, A. R. A.; Pal, S. K.; Voss, M. H.; Sharma, P.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Effect of concomitant medication use on outcomes of ties and placebo arms of the COU-AA-301 and COU-AA-302 studies of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Hamilton, R. J.; Li, J. H.; Naini, V.; San Kheoh, T.; De Porre, P.; Molina, A.; Lelbowitz-Amit, R.; de Bono, J. S.; Scher, H. I.; Ryan, C. J.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save